Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Science (New York, N.Y.)|July 16, 2026
Lymph nodes now optionalWilliam K Decker
Cytokine & Growth Factor Reviews|August 7, 2009
Bioimmunoadjuvants for the treatment of neoplastic and infectious disease: Coley's legacy revisitedWilliam K Decker, Amar Safdar
Cytokine & Growth Factor Reviews|August 25, 2011
Cytokine adjuvants for vaccine therapy of neoplastic and infectious diseaseWilliam K Decker, Amar Safdar
Expert Review of Vaccines|July 14, 2010
Dendritic cell vaccines for the immunocompromised patient: prevention of influenza virus infectionWilliam K Decker, Amar Safdar
Human Vaccines|April 3, 2008
Progress in dendritic cell immunotherapy: elucidating the enigma of Th-1 polarizationWilliam K Decker, Elizabeth J Shpall
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2006
Dendritic cell immunotherapy for the treatment of neoplastic diseaseWilliam K Decker, Dongxia Xing, Elizabeth J Shpall
Frontiers in Immunology|April 1, 2025
High tumor CD161 expression predicts a survival advantage and marks a Th1-skewed microenvironmentBriana Amicarella Burns, Manasvi Chandra, Vanaja Konduri, et al.
Expert Review of Neurotherapeutics|April 3, 2013
Clinical trials in cellular immunotherapy for brain/CNS tumorsJetan Badhiwala, William K Decker, Michael E Berens, et al.
The Journal of Infectious Diseases|March 6, 2013
Modeling dendritic cell vaccination for influenza prophylaxis: potential applications for niche populationsVanaja Konduri, William K Decker, Matthew M Halpert, et al.
Cancer Letters|July 16, 2005
A retrogen plasmid-based vaccine generates high titer antibody responses against the autologous cancer antigen survivin and demonstrates anti-tumor efficacyWilliam K Decker, Jianxia Qiu, Farhang Farhangfar, et al.
Pageof 5